Evotec stock gains 4.00% to EUR 2.86 premarket
Published on 11/19/2026 at 08:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEvotec business and market position
- Evotec develops drug candidates and drug-discovery technologies for pharmaceutical and biotechnology partners.
- The company combines Shared R&D with its Just - Evotec Biologics business.
Evotec stock starts Thursday higher
Evotec stock traded at EUR 2.86 on Lang & Schwarz at 08:11 CET on Thursday, November 19, 2026, 4.00 percent above the Xetra close of Wednesday, November 18, 2026, at EUR 2.75.
Evotec develops drug candidates and drug-discovery technologies for pharmaceutical and biotechnology partners. Its business combines Shared R&D with Just - Evotec Biologics, according to Evotec Investor Relations.
The broader German market can be followed through current market reports.
Disclaimer...
en | DE0005664809 | EVOTEC SE | boerse | 70534393 | bgmi
